JP2004522795A5 - - Google Patents

Download PDF

Info

Publication number
JP2004522795A5
JP2004522795A5 JP2002569853A JP2002569853A JP2004522795A5 JP 2004522795 A5 JP2004522795 A5 JP 2004522795A5 JP 2002569853 A JP2002569853 A JP 2002569853A JP 2002569853 A JP2002569853 A JP 2002569853A JP 2004522795 A5 JP2004522795 A5 JP 2004522795A5
Authority
JP
Japan
Prior art keywords
group
alkyl
compound
halogen
hexenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002569853A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004522795A (ja
Filing date
Publication date
Priority claimed from GB0105335A external-priority patent/GB2372741A/en
Application filed filed Critical
Publication of JP2004522795A publication Critical patent/JP2004522795A/ja
Publication of JP2004522795A5 publication Critical patent/JP2004522795A5/ja
Withdrawn legal-status Critical Current

Links

JP2002569853A 2001-03-03 2002-03-03 Ｃ２，８−二置換アデノシン誘導体およびそれらの種々の使用 Withdrawn JP2004522795A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0105335A GB2372741A (en) 2001-03-03 2001-03-03 C2,8-Disubstituted adenosine derivatives and their different uses
PCT/IL2002/000161 WO2002070534A1 (en) 2001-03-03 2002-03-03 C2, 8-disubstituted adenosine derivatives and their different uses

Publications (2)

Publication Number Publication Date
JP2004522795A JP2004522795A (ja) 2004-07-29
JP2004522795A5 true JP2004522795A5 (enExample) 2005-06-30

Family

ID=9909950

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002569853A Withdrawn JP2004522795A (ja) 2001-03-03 2002-03-03 Ｃ２，８−二置換アデノシン誘導体およびそれらの種々の使用

Country Status (7)

Country Link
US (1) US7112574B2 (enExample)
EP (1) EP1368364B1 (enExample)
JP (1) JP2004522795A (enExample)
AT (1) ATE340185T1 (enExample)
DE (1) DE60214830D1 (enExample)
GB (1) GB2372741A (enExample)
WO (1) WO2002070534A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1813623B1 (en) * 2004-09-17 2011-11-09 Kissei Pharmaceutical Co., Ltd. Purinenucleoside derivative modified in 8-position and medicinal use thereof
GT200500281A (es) 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0500785D0 (en) 2005-01-14 2005-02-23 Novartis Ag Organic compounds
US20090118220A1 (en) * 2006-04-03 2009-05-07 Astrazeneca Ab Substituted adenines and the uses thereof
AR060607A1 (es) 2006-04-21 2008-07-02 Novartis Ag Derivados de purina,composiciones farmaceuticas que los contienen, metodo de preparacion y usos en enfermedades obstructivas o inflamatorias de las vias respiratorias.
GB0607950D0 (en) 2006-04-21 2006-05-31 Novartis Ag Organic compounds
EP1889846A1 (en) 2006-07-13 2008-02-20 Novartis AG Purine derivatives as A2a agonists
EP1903044A1 (en) 2006-09-14 2008-03-26 Novartis AG Adenosine Derivatives as A2A Receptor Agonists
CN108129535A (zh) * 2017-12-19 2018-06-08 兰州奥凯化工公司 8-溴腺苷的合成方法
AU2022244979B2 (en) * 2021-03-26 2024-06-20 Future Medicine Co., Ltd. Adenosine derivative having antagonistic action on a2a and a3 adenosine receptors and method for preparing same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968102A (en) * 1974-04-18 1976-07-06 Kohjin Co., Ltd. S-substituted-2-thioadenosines
US3966102A (en) * 1974-08-08 1976-06-29 Standard Oil Company Single unit carrier for drinkware
US5189027A (en) * 1990-11-30 1993-02-23 Yamasa Shoyu Kabushiki Kaisha 2-substituted adenosine derivatives and pharmaceutical compositions for circulatory diseases
US5278150A (en) * 1992-04-24 1994-01-11 Whitby Research, Inc. 2-hydrazoadenosines and their utility for the treatmeat of vascular conditions
US6514949B1 (en) * 1994-07-11 2003-02-04 University Of Virginia Patent Foundation Method compositions for treating the inflammatory response
US5877180A (en) * 1994-07-11 1999-03-02 University Of Virginia Patent Foundation Method for treating inflammatory diseases with A2a adenosine receptor agonists
US6448235B1 (en) * 1994-07-11 2002-09-10 University Of Virginia Patent Foundation Method for treating restenosis with A2A adenosine receptor agonists
US5998423A (en) * 1996-10-08 1999-12-07 Therasys, Inc. Methods for modulating melanin production
GB9723566D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
AU5294100A (en) * 1999-05-27 2000-12-18 University Of Virginia Patent Foundation Method and compositions for treating the inflammatory response
US6180615B1 (en) 1999-06-22 2001-01-30 Cv Therapeutics, Inc. Propargyl phenyl ether A2A receptor agonists
WO2001040799A2 (en) * 1999-12-03 2001-06-07 Cv Therapeutics, Inc. Method of identifying partial adenosine a1 receptor agonists and their use in the treatment of arrhythmias
US6605597B1 (en) * 1999-12-03 2003-08-12 Cv Therapeutics, Inc. Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives

Similar Documents

Publication Publication Date Title
JP2022043078A5 (enExample)
JP2004522795A5 (enExample)
JP2006519818A5 (enExample)
JP2001525411A5 (enExample)
JP2007510619A5 (enExample)
JP2001525322A5 (enExample)
CN1285843A (zh) 化合物
JP2005053931A5 (enExample)
SK95093A3 (en) Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b
JP2004522706A5 (enExample)
JP2020506951A5 (enExample)
JP2009538336A5 (enExample)
JP2004537516A5 (enExample)
JP2002520316A5 (enExample)
JP2005511547A5 (enExample)
RU2006106727A (ru) Селективный синтез cf3-замещенных пиримидинов
JP2001518459A5 (enExample)
RU2005121908A (ru) Производные зн-хиназолин-4-она
JP2004525178A5 (enExample)
JP2005511602A5 (enExample)
JP2022116171A5 (enExample)
JP2007506664A5 (enExample)
CN1152857C (zh) 用作多巴胺受体的苯磺酰胺-苯乙胺
RU2011101661A (ru) Пиримидилсульфонамидное производное и его применение для лечения хемокин-опосредованных заболеваний
JP2013530948A5 (enExample)